These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 17412283

  • 1. Expression of programmed-death receptor ligands 1 and 2 may contribute to the poor stimulatory potential of murine immature dendritic cells.
    Chen C, Qu QX, Huang JA, Zhu YB, Ge Y, Wang Q, Zhang XG.
    Immunobiology; 2007; 212(3):159-65. PubMed ID: 17412283
    [Abstract] [Full Text] [Related]

  • 2. Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation.
    Kuipers H, Muskens F, Willart M, Hijdra D, van Assema FB, Coyle AJ, Hoogsteden HC, Lambrecht BN.
    Eur J Immunol; 2006 Sep; 36(9):2472-82. PubMed ID: 16917960
    [Abstract] [Full Text] [Related]

  • 3. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production.
    Brown JA, Dorfman DM, Ma FR, Sullivan EL, Munoz O, Wood CR, Greenfield EA, Freeman GJ.
    J Immunol; 2003 Feb 01; 170(3):1257-66. PubMed ID: 12538684
    [Abstract] [Full Text] [Related]

  • 4. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses.
    Butte MJ, Keir ME, Phamduy TB, Sharpe AH, Freeman GJ.
    Immunity; 2007 Jul 01; 27(1):111-22. PubMed ID: 17629517
    [Abstract] [Full Text] [Related]

  • 5. Overexpression of programmed death ligand 1 in dendritic cells inhibits allogeneic lymphocyte activation in mice.
    Li W, Wang X, Chen R, Zhu H, Chen G, Sun X.
    J Surg Res; 2012 Aug 01; 176(2):e79-87. PubMed ID: 22381170
    [Abstract] [Full Text] [Related]

  • 6. Programmed cell death 1 (PD-1) and its ligand PD-L1 are required for allograft tolerance.
    Wang L, Han R, Hancock WW.
    Eur J Immunol; 2007 Oct 01; 37(10):2983-90. PubMed ID: 17899549
    [Abstract] [Full Text] [Related]

  • 7. Roles of programmed death-1 (PD-1)/PD-1 ligands pathway in the development of murine acute myocarditis caused by coxsackievirus B3.
    Seko Y, Yagita H, Okumura K, Azuma M, Nagai R.
    Cardiovasc Res; 2007 Jul 01; 75(1):158-67. PubMed ID: 17434153
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B, Mitsdoerffer M, Kieseier BC, Chen L, Hartung HP, Weller M, Wiendl H.
    J Neuroimmunol; 2004 Oct 01; 155(1-2):172-82. PubMed ID: 15342209
    [Abstract] [Full Text] [Related]

  • 10. Expression of programmed death 1 and its ligands in the liver of autoimmune hepatitis C57BL/6 mice.
    Cao J, Liu FX, Yu MX.
    Chin Med J (Engl); 2009 Aug 20; 122(16):1941-6. PubMed ID: 19781375
    [Abstract] [Full Text] [Related]

  • 11. Limited costimulatory molecule expression on renal tubular epithelial cells impairs T cell activation.
    Waeckerle-Men Y, Starke A, Wahl PR, Wüthrich RP.
    Kidney Blood Press Res; 2007 Aug 20; 30(6):421-9. PubMed ID: 17975322
    [Abstract] [Full Text] [Related]

  • 12. PD-1-PD-L1 pathway is involved in suppressing alloreactivity of heart infiltrating t cells during murine gvhd across minor histocompatibility antigen barriers.
    Schilbach K, Schick J, Wehrmann M, Wollny G, Simon P, Schlegel PG, Eyrich M.
    Transplantation; 2007 Jul 27; 84(2):214-22. PubMed ID: 17667813
    [Abstract] [Full Text] [Related]

  • 13. Essential role of B7-H1 in double-stranded RNA-induced augmentation of an asthma phenotype in mice.
    Matsumoto K, Kan-O K, Eguchi-Tsuda M, Fukuyama S, Asai Y, Matsumoto T, Moriwaki A, Matsunaga Y, Tsutsui H, Kawai T, Takeuchi O, Akira S, Yagita H, Azuma M, Nakanishi Y, Inoue H.
    Am J Respir Cell Mol Biol; 2011 Jul 27; 45(1):31-9. PubMed ID: 20802088
    [Abstract] [Full Text] [Related]

  • 14. PD-L2 is a second ligand for PD-1 and inhibits T cell activation.
    Latchman Y, Wood CR, Chernova T, Chaudhary D, Borde M, Chernova I, Iwai Y, Long AJ, Brown JA, Nunes R, Greenfield EA, Bourque K, Boussiotis VA, Carter LL, Carreno BM, Malenkovich N, Nishimura H, Okazaki T, Honjo T, Sharpe AH, Freeman GJ.
    Nat Immunol; 2001 Mar 27; 2(3):261-8. PubMed ID: 11224527
    [Abstract] [Full Text] [Related]

  • 15. High-level expression of B7-H1 molecules by dendritic cells suppresses the function of activated T cells and desensitizes allergen-primed animals.
    Kim HK, Guan H, Zu G, Li H, Wu L, Feng X, Elmets C, Fu Y, Xu H.
    J Leukoc Biol; 2006 Apr 27; 79(4):686-95. PubMed ID: 16461745
    [Abstract] [Full Text] [Related]

  • 16. Suppressed T-cell activation by IFN-gamma-induced expression of PD-L1 on renal tubular epithelial cells.
    Schoop R, Wahl P, Le Hir M, Heemann U, Wang M, Wüthrich RP.
    Nephrol Dial Transplant; 2004 Nov 27; 19(11):2713-20. PubMed ID: 15353579
    [Abstract] [Full Text] [Related]

  • 17. [Bioimmunological characteristics of mature or immature murine dendritic cells].
    Wang KL, Guo L, Shi RF, Wang JL, Dong SH.
    Zhonghua Yi Xue Za Zhi; 2011 Dec 06; 91(45):3225-8. PubMed ID: 22333110
    [Abstract] [Full Text] [Related]

  • 18. PD-L1 partially protects renal tubular epithelial cells from the attack of CD8+ cytotoxic T cells.
    Waeckerle-Men Y, Starke A, Wüthrich RP.
    Nephrol Dial Transplant; 2007 Jun 06; 22(6):1527-36. PubMed ID: 17339272
    [Abstract] [Full Text] [Related]

  • 19. Keratinocyte-associated B7-H1 directly regulates cutaneous effector CD8+ T cell responses.
    Ritprajak P, Hashiguchi M, Tsushima F, Chalermsarp N, Azuma M.
    J Immunol; 2010 May 01; 184(9):4918-25. PubMed ID: 20363965
    [Abstract] [Full Text] [Related]

  • 20. Fine-tuned expression of programmed death 1 ligands in mature dendritic cells stimulated by CD40 ligand is critical for the induction of an efficient tumor specific immune response.
    Gu T, Zhu YB, Chen C, Li M, Chen YJ, Yu GH, Ge Y, Zhou SY, Zhou H, Huang Y, Qiu YH, Zhang XG.
    Cell Mol Immunol; 2008 Feb 01; 5(1):33-9. PubMed ID: 18318992
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.